https://www.selleckchem.com/products/su056.html
lutionize consumer and healthcare markets. © 2020 Published by Elsevier Ltd.Background Aims Biliary tract tumors are uncommon but highly aggressive malignancies with poor survival outcomes. Due to their low incidence, research into effective therapeutics has been limited. Novel research platforms for pre-clinical studies are desperately needed. We sought to develop a patient-derived biliary tract cancer xenograft catalog. Methods With appropriate consent and approval, surplus malignant tissues were obtained from surgical resection o
Aimer
Commentaire
Partagez
